Hepatology - European Medical Journal

Continue

Hepatology

Filter
EMJ
22 Jun 2015

New Biomarkers Could Shine Beacon for Personalised Hepatitis C Therapy

BLOOD tests can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy. “While highly effective direct-acting…
EMJ
22 Jun 2015

Starved T Cells Enable Undercover Liver Infection by Hepatitis B

HEPATITIS B has been shown to stimulate processes that deprive the body’s immune cells of key nutrients that they need to function. The findings explain…
EMJ
30 Mar 2015

Endosialin an Integral Cog in the Liver Fibrosis Machine

DISCOVERY of a new molecule on the surface of hepatic stellate cells has broadened knowledge of the underlying mechanisms that cause liver fibrosis…
EMJ
30 Mar 2015

Plant Compounds Represent a Budding Option for Non-Alcoholic Fatty Liver Disease (NAFLD) Treatment

Plant compounds represent a budding option for Non-Alcoholic Fatty Liver Disease (NAFLD) treatment. Read the article and find out more
EMJ
4 Feb 2015

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…
EMJ
12 Jan 2015

Artificial Liver Leads the Way as New Life-Saver

BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or…
EMJ
6 Jan 2015

Liver Cancer Menace May Lie in Surrounding Immunity

MACROPHAGES may constitute the next target for liver cancer treatment as the presence of epidermal growth factor receptor (EGFR) in the cells…
EMJ
6 Jan 2015

Gene Culprit behind Metabolic Syndrome Revealed

HEALTHY gut microbiota may be the key to tackling metabolic syndrome (MetS); when a particular gene, known as Toll-like receptor 5 (TLR5), is…